Menu
MorphoSys US

Investor & Media information

You are here

  1. Home
  2. Media and investors
  3. Investor & Media information

MorphoSys is strictly committed to the principle of fair disclosure. One of the most important foundations of our corporate communication is to inform all stakeholders simultaneously and comprehensively about the situation of the Company. We pay great attention to transparent and timely communication.

Corporate media releases

Date
Title

2020

  1. 27/05/2020
    MorphoSys AG Reports Outcome of Annual General Meeting 2020
  2. 20/05/2020
    MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for Tafasitamab
  3. 14/05/2020
    MorphoSys to Present Data on Tafasitamab at the ASCO and EHA Virtual Meetings
  4. 14/05/2020
    MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with r/r DLBCL
  5. 06/05/2020
    MorphoSys Reports First Quarter 2020 Results
  6. 30/04/2020
    Invitation to MorphoSys' First Quarter 2020 Results Conference Call on May 7, 2020
  7. 27/04/2020
    MorphoSys and I-Mab Announce First Patient Dosed in Phase 3 Clinical Trial of MOR202/TJ202 in r/r Multiple Myeloma in Mainland China
  8. 21/04/2020
    MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer
  9. 06/04/2020
    MorphoSys Provides Update on Impact of COVID-19 on Business Operations and Precautionary Measures
  10. 18/03/2020
    MorphoSys Presents Results for Fiscal Year 2019

Pages

Order form for publications and reports

Ad-hoc releases

Sorry, but there are no ad-hoc releases available for the selected year.

Pages

Conferences

Friday, February 26, 2021
Webcast: 10th Annual SVB Leerink Global Healthcare Conference

Dr. Jean-Paul Kress presents the Company at the 10th Annual SVB Leerink Global Healthcare Conference on Friday, February 26, 2021, 02:20pm EST (08:20pm CET).

Go to Webcast...

Archive

Date
Title
MP3

2021

  1. 02/26/2021

    Webcast: 10th Annual SVB Leerink Global Healthcare Conference

  2. 02/11/2021

    Guggenheim Healthcare Talks, 2021 Oncology Day

  3. 01/13/2021

    Webcast: 39th Annual J.P. Morgan Healthcare Conference

2020

  1. 12/16/2020

    Webcast: JMP Securities Hematology Summit

  2. 11/17/2020

    Stifel 2020 Virtual HC Conference

  3. 11/12/2020

    Conference Call and Webcast: Q3/9M 2020 Financial Results

  4. 09/29/2020

    Conference Call and Webcast: MorphoSys & Incyte Tafasitamab Expert Event

  5. 08/06/2020

    Conference Call and Webcast: Q2/H1 2020 Financial Results

  6. 08/03/2020

    Joint MorphoSys and Incyte Conference Call

  7. 06/18/2020

    Webcast: JMP Securities Hematology and Oncology Forum

  8. 06/10/2020

    Webcast: Goldman Sachs 41st Annual Global Healthcare Conference

  9. 06/03/2020

    Webcast: Jefferies 2020 Healthcare Conference

  10. 05/07/2020

    Conference Call and Webcast: Q1 2020 Financial Results

  11. 03/19/2020

    Conference Call and Webcast: Year End 2019

Pages

Company Update

Date
Venue
Download

2020

  1. 01/13/2021
    Company Update

Pictures

Technology

Ylanthia

Ylanthia technology

Slonomics

Slonomics technology

HuCAL

HuCAL antibody library

HuCAL

Scientist working with the HuCAL library

Lab shots

Antibody purification

Scientist in protein chemistry lab

Daily work

MorphoSys scientist working in laboratory

Scientist with petri dishes

MorphoSys scientist handling petri dishes

Cell culture experiment

MorphoSys scientist in cell culture lab

Miscellaneous

MorphoSys Building Planegg

View of the Building of MorphoSys in Planegg/Munich, Germany

MorphoSys Building Planegg

Entrance of the Building of MorphoSys in Planegg/Munich, Germany

MorphoSys Logo
MorphoSys Footage Video

Copyright notice: The photos provided for download on this website can be used free of charge in the context of editorial reporting with the indication of the photo credit "©MorphoSys AG".

 

You are leaving morphosys.com and will be transferred to the MorphoSys US website which is intended for US residents.

Do you wish to proceed?

Yes No

You are leaving morphosys.com and will be transferred to the MorphoSys US website which is intended for US residents.

Do you wish to proceed?

Yes No

You are leaving morphosys.com and will be transferred to the Monjuvi(®) US website which is intended for US residents.

Do you wish to proceed?

Yes No